Defective production of reactive oxygen intermediates (ROI) in a patient with recurrent amebic liver abscess

American Journal of Tropical Medicine and Hygiene

Volumn 67, Issue 6, 2002, Pages 632-635

  Moran, Patricia ^a,b,c,d   Rico, Guadalupe ^a,b,c,d   Ramiro, Manuel ^a,b,c,d   Olvera, Horacio ^a,b,c,d   Ramos, Fernando ^a,b,c,d   Gonzalez, Enrique ^a,b,c,d   Valadez, Alicia ^a,b,c,d   Curiel, Octavio ^a,b,c,d   Melendro, Emma I ^a,b,c,d   Ximenez, Cecilia ^a,b,c,d  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

^c HOSPITAL REGIONAL 1 DE OCTUBRE   (Mexico)

^d Hospital Angeles Clinica Londres   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTOZOON ANTIBODY; REACTIVE OXYGEN METABOLITE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CASE REPORT; CELL ASSAY; CELL MIGRATION; CHEMOLUMINESCENCE; ENTAMOEBA HISTOLYTICA; FOLLOW UP; HOST RESISTANCE; HUMAN; INFECTION RISK; LIVER AMEBIASIS; MALE; MONONUCLEAR CELL; MONONUCLEAR PHAGOCYTE; POLYMORPHONUCLEAR CELL; RECURRENT DISEASE; RESPIRATORY BURST;

ENTAMOEBA HISTOLYTICA; PROTOZOA;

EID: 0036908289     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2002.67.632     Document Type: Article

References (16)

1. Kretschmer RR, López-Osuna M, 1990. Effector mechanisms and immunity to amebas. Kretschmer RR, ed. Amebiasis: Infection and Disease by Entamoeba Histolytica. Boca Raton, FL: CRC Press, 105-122.
2. Ghadirian E, Meerovitch E, 1982. Macrophage requirement for host defense against experimental hepatic amoebiasis in the hamster. Parasite Immunol 4: 219-225.
3. Salata RA, Pearson RD, Ravdin JI, 1985. Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by activated macrophage. J Clin Invest 76: 491-499.
4. De Leén A, 1970. Pronóstico tardío en el absceso hepático amibiano. Arch Invest Med (Mex) 1: 205-206.
5. Treviño GM, Escandón RC, Escobedo PJ, Hernández RJ, Fierro HH, 1994. Amebiasis in the epidemiologic transition in Mexico: Its morbidity and mortality trends in the Mexican Institute of Social Security. Arch Med Res 25: 393-399.
6. World Health Organization, 1998. The World Health Report. Life in the 21st Century, a Vision for All. Geneva: World Health Organization.
7. Espinosa-Cantellano M, Martínez-Palomo A, 2000. Pathogenesis of intestinal amebiasis. From molecules to disease. Clin Microbiol Rev 13: 318-331.
8. Ramiro M, Morán P, Olvera O, Curiel O, González E, Ramos M, Melendro EI, Ximénez C, 2000. Reincidence of amebic liver abscess: A case report. Arch Med Res 31: S1-S3.
9. Stephen PJ, 1994. Measurement of basic immunologic characteristics of human mononuclear cells. Coligan JE, Kruisbeek AM, Margulis DH, Shevach EM, Strober W, eds. Current Protocols in Immunology. New York: John Wiley & Sons, 7.11.1-7.12.6
10. Schain DC, Salata RA, Ravdin JI, 1992. Human T-lymphocyte proliferation, lymphokine production, and amebicidal activity elicited by the galactose-inhibitable adherence protein of Entamoeba histolytica. Infect Immun 60: 2143-2146.
11. Kretschmer R, Collado ML, Pacheco MG, Salinas M, López Osuna M, Lucona M, Castro E, Arellano J, 1985. Inhibition of human monocyte locomotion by products of axenically grown Entamoeba histolytica. Parasite Immunol 7: 527-543.
12. Rico G, Díaz-Guerra O, Giménez-Scherer JA, Kretschmer RR, 1992. Effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica upon the respiratory burst of human leukocytes. Arch Med Res 23: 157-159.
13. González E, Rico G, Morán P, Ramos F, García G, Padilla G, Ramiro M, Valdéz E, Muñoz O, Gómez A, Kretschmer R., Melendro EI, Ximénez C, 2000. Purification and biochemical characterization of three cysteine proteases of Entamoeba histolytica with potential application in epidemiologic trials. Arch Med Res 31: 49S-52S.
14. Ximénez C, Sosa O, Leyva O, Morán O, Levva O, Morán P, Ramiro M, 1992. Western blot of E. histolytica antigen fractions: Reactivity analysis with sera from intestinal amoebiasis patients. Ann Trop Med Parasitol 86: 121-127.
15. Gómez A, Leyva O, Martínez MC, Garduño G, Ramos F, Morán P, Melendro EI, Muñoz O, Ximénez C, 1997. Prospective study of Entamoeba dispar infection in a cohort of mothers and their infants: Relationship to serum antibody response. Am J Trop Med Hyg 57: 530-537.
16. Martínez-Palomo A, Espinosa Cantellano M, 1998. Intestinal amoebae. In: Cox FEG, Kreir JP, Wakelin D, eds. Topley & Wilson's Microbiology and Microbial Infection. 9 Ed. Vol. 5. Parasitology. London: Arnold, 157-177.